HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gilbert-Barness, E. Search for Related Content PubMed PubMed Citation Articles by Gilbert-Barness, E.

Metabolic Cardiomyopathy and Conduction System Defects in Children

Address correspondence to Enid Gilbert-Barness, M.D., Department of Pathology, Tampa General Hospital, PO Box 1287, Tampa, FL 33601, USA; tel 813 844 7565; fax 813 844 1427; e-mail egilbert{at}tgh.org.

Metabolic cardiomyopathies include amino acid, lipid and mitochondrial disorders, as well as storage diseases. A number of metabolic disorders are associated with both myopathy and cardiomyopathy. These include the glycogen storage diseases, ie, acid maltase deficiency (infantile, childhood, and adult onset), McArdle disease, and debrancher and brancher deficiencies. Disorders of lipid metabolism include systemic carnitine deficiency and abnormalities of carnitine palmitoyltransferase (CPT), long-chain acyl-CoA dehydrogenase, and multiple acyl-CoA dehydrogenase. Disorders of mitochondrial metabolism affect complex I, II, III, IV and V, in addition to multiple respiratory chain defects. These may cause either hypertrophic or dilated cardiomyopathy. In addition, cardiomyopathy is frequently a component part of the storage disorders, including mucopolysaccharidosis, mucolipidosis, Fabry disease, gangliosidosis, and neuronal ceroid lipofuscinosis. Primary hypertrophic cardiomyopathy is caused by mutations in one of the genes that encode proteins of the cardiac sarcomere. Mutations in different genes are attended by different prognoses and different risks of sudden death. Mutations of the genes for myosin binding protein C (MBP-C) and tropomyosin have low penetrance and cause mild forms of primary hypertrophic cardiomyopathy, while mutations of the troponin T and B-myosin genes carry a worse prognosis. Conduction disorders result in cardiac arrhythmias that may be fatal. Histiocytoid cardiomyopathy is usually an autosomal recessive disorder that results in the presence of abnormal Purkinje cells that interfere with normal cardiac conduction. Other conduction defects include arrhythmogenic right ventricular dysplasia (ARVD), congenital heart block, noncompaction of the left ventricle, and long Q-T syndrome (LQTS). The genetic loci for LQTS reside usually in the potassium channel, and, less frequently, in the sodium channel (channelopathies). Although the histological appearance of some of these disorders may be diagnostic, molecular analysis is necessary to define clearly the particular type of cardiomyopathy.

Keywords: cardiomyopathies, mitochondrial disorders, glycogen storage diseases, lipid disorders, cardiac conduction disorders, mucopolysaccharoidoses

This article has been cited by other articles:

				H. B. Gelberg Purkinje Fiber Dysplasia (Histiocytoid Cardiomyopathy) with Ventricular Noncompaction in a Savannah Kitten Vet. Pathol., July 1, 2009; 46(4): 693 - 697. [Abstract] [Full Text] [PDF]

				G. I. Fishman Understanding Conduction System Development: A Hop, Skip and Jump Away? Circ. Res., April 29, 2005; 96(8): 809 - 811. [Full Text] [PDF]